Prior authorization in medical billing is a payer-required approval that providers must obtain before delivering specific procedures, imaging, medications, or equipment. Without it, insurers can deny the claim entirely. RevalonMD's AAPC-certified team secures pre-authorization across all major payers, preventing no-auth write-offs before care is delivered.
99% first-pass figure is a RevalonMD target — 99% first-pass claim rate is a RevalonMD operating target; individual practice results vary by specialty, payer mix, and documentation quality.
We review your payer mix, no-auth write-offs, and authorization turnaround, then return a written findings summary with a recommended workflow. Practice profile only — no PHI required to book.
Most payers require prior authorization for advanced imaging (MRI, CT, PET), elective and complex surgeries, specialty and biologic medications, durable medical equipment, and certain specialist referrals. Exact requirements vary by payer, plan, and state — making a payer-specific authorization workflow essential for any practice billing beyond basic E&M.
Requirements differ sharply by service type. RevalonMD maintains payer-specific authorization matrices for each category below — so your team never guesses which order, study, or drug needs a pre-cert.
Advanced imaging — MRI, CT, PET, and nuclear medicine studies — requires prior authorization from virtually every major commercial payer and Medicare Advantage plan. The payer applies InterQual or MCG clinical criteria to verify medical necessity. Radiology and orthopedic practices carry some of the highest PA volumes of any specialty.
Elective and complex surgeries — orthopedic joint replacements, spine procedures, bariatric surgery, and general surgical interventions — require prior authorization in most payer contracts. The documentation packet must include diagnosis codes (ICD-10-CM FY2026, CMS/NCHS), procedure codes (CPT 2026, AMA), operative notes, and clinical justification tied to the payer's criteria.
Specialty medications, biologics, infusion therapies, and oncology drugs typically carry step therapy requirements before a payer approves the preferred agent. Step therapy requires documenting that the patient tried and failed at least one formulary-preferred alternative. RevalonMD manages step therapy documentation and formulary exception requests on the provider's behalf.
Durable medical equipment — CPAP/BiPAP machines, power wheelchairs, infusion pumps, and orthotic braces — requires prior authorization from most payers. DME requests must include a certificate of medical necessity, a prescription from the treating provider, and supporting clinical documentation. Home health services frequently require concurrent authorization for episode extensions.
Code-year note: CPT 2026 (AMA) and ICD-10-CM FY2026 (CMS/NCHS, effective October 1, 2025) references are verified by the RevalonMD Coding Director at each refresh. Specialty CPT code families branch to the 56 specialty child pages.
To obtain prior authorization, a provider submits a request with clinical documentation and medical-necessity evidence to the payer before delivering service. The payer issues an authorization number — typically within 72 hours (urgent) or 7 calendar days (standard) under CMS-0057-F, the federal rule effective January 1, 2026.
The eight steps are sequential: a benefit-verification miss at step one becomes a denial at step six. RevalonMD runs every step inside your existing EHR and the payer’s portal, so defects are caught before submission rather than appealed after.
Once a payer issues an authorization number, RevalonMD records it in the patient chart and on the CMS-1500 claim form in Field 23 (or the equivalent EDI field), then forwards it to billing for same-day submission — closing the gap where most no-auth write-offs are created.
Under CMS-0057-F (January 17, 2024 Final Rule), Medicare Advantage, Medicaid, CHIP, and Qualified Health Plan payers must respond to urgent prior authorization requests within 72 hours and standard requests within 7 calendar days — effective January 1, 2026. By January 1, 2027, payers must also support HL7 FHIR electronic prior authorization APIs.
Electronic prior authorization replaces phone-and-fax PA with digital submission. The two most widely used platforms are CoverMyMeds (leading for medication PA, integrated with most major EHRs) and Availity (the dominant multi-payer portal for commercial PA submissions).
RevalonMD’s workflow is EHR-agnostic — we submit via CoverMyMeds, Availity, and individual payer portals regardless of the EHR your practice runs, and we are tracking the January 1, 2027 HL7 FHIR API mandate to update submission protocols as payers comply.
Prior authorization is the single largest administrative burden in most practices. According to the 2025 AMA Prior Authorization Physician Survey, physicians complete an average of 40 PA requests per week and spend 13 hours of physician and staff time on them — time that does not bill.
Sources: 2025 AMA Prior Authorization Physician Survey (ama-assn.org); AMA, “Prior Authorization Reform Pledge Falls Short,” May 13, 2026. RevalonMD absorbs this burden from your practice so clinical staff focus on care, not payer portals.
A denied prior authorization can be appealed through a peer-to-peer review — a direct call between the treating physician and the payer's medical director. If denied again, a formal written appeal follows. Under CMS-0057-F, payers must now provide specific denial reasons, making targeted appeals faster and more actionable.
Beyond the standard pre-service request, four concepts decide whether revenue is protected or written off. RevalonMD manages each on the provider’s behalf.
Step therapy (also called 'fail first') requires a patient to try and fail at least one lower-cost or formulary-preferred medication before the payer authorizes the prescribed agent. RevalonMD documents step therapy compliance for every medication PA that triggers a formulary exception, reducing denial risk from missing fail-first evidence.
A gold card exemption lets providers with a strong PA approval history — typically ≥90% over a defined period — bypass the authorization requirement for specific services or payers. Programs vary by payer and state, and some states mandate exemptions by law. RevalonMD tracks gold card eligibility for practices that qualify.
Retro authorization is payer approval requested after a service is delivered — typically when a patient presents in an emergency and pre-service approval was not obtainable. Most payers require retro requests within 24–72 hours of service. Retro requests carry a higher denial rate and demand strong documentation of medical necessity and urgency.
Concurrent authorization is a payer review during ongoing treatment — most often inpatient hospital stays, skilled nursing stays, or long-term therapy. The payer may request additional clinical information at intervals to confirm continued medical necessity. Missing a concurrent review deadline can deny the remaining inpatient days.
When an authorization is denied, RevalonMD’s denial team can manage prior authorization denials through peer-to-peer review and formal appeal — using the specific denial reason CMS-0057-F now requires payers to provide.
Benchmarks describe the average; an actual workflow shows the mechanism. The representative engagement below is the pattern RevalonMD sees most often in surgical specialty groups.
A 12-physician orthopedic group in Texas was experiencing elevated no-auth write-offs on joint replacement and spine surgery authorizations across multiple commercial payers, including UnitedHealthcare and Cigna. Its three billing FTEs spent most of their time managing payer portals and follow-up calls rather than on claim submission and A/R recovery.
The practice's billing staff, previously consumed by authorization management, redirected focus to denial appeals and A/R recovery — the highest-value activities for the billing department. RevalonMD provides the same structured authorization workflow for 50+ specialties across all 50 states, regardless of EHR system.
Illustrative scenario — not a specific named client. Revenue and workflow outcomes are representative and depend on payer mix, specialty, and volume.
Compared with an in-house PA team or a generic billing company, RevalonMD pairs national scope with credentialed staff and a signed BAA. Specialty and state coverage, EHR flexibility, and CMS-0057-F-ready protocols are the differentiators no generic vendor matches.
| Capability | In-house team | Generic billing company | RevalonMD |
|---|---|---|---|
| Specialty coverage | Limited to practice specialty | 10–20 specialties | 50+ specialties |
| State coverage | Your licensed states | Varies | All 50 states |
| EHR compatibility | Your EHR only | Varies | EHR-agnostic |
| AAPC / AHIMA certification | Varies | Varies | Required for all staff |
| BAA before any PHI access | N/A | Varies | With every client |
| CMS-0057-F workflow updates | Manual | Manual | Protocols updated |
| First-pass claim rate | Varies | Varies | 99% (target) † |
| Starting billing rate | Salary + benefits | 5%–8% | 2.99% (target) † |
† First-pass claim rate (99%) and starting billing rate (2.99%) are RevalonMD operating targets — 99% first-pass claim rate is a RevalonMD operating target; individual practice results vary by specialty, payer mix, and documentation quality.
RevalonMD manages prior authorization end-to-end for practices across 50+ specialties in all 50 states — benefit verification, clinical documentation assembly, ePA submission, auth tracking, peer-to-peer coordination, and denial appeals. Your team spends time on patient care, not payer portals.
Starting billing rate: 2.99% (target) · BAA signed with every client before any PHI access.
Phone: (307) 333-8199
Email: support@revalonmd.com
Hours: Mon–Fri 8am–6pm EST · Sat 9am–1pm EST
Practice profile + contact info only — no PHI required to book.
Reviewed by RevalonMD Provider Credentialing Team (CPCS, CPMSM — NAMSS) · Last reviewed: June 2026
Prior authorization (also called pre-authorization or precertification) is a payer-required approval that healthcare providers must obtain before delivering specific procedures, medications, imaging, or equipment. It confirms medical necessity and guarantees reimbursement — preventing claim denials and no-auth write-offs that directly impact practice revenue.
Under CMS-0057-F, effective January 1, 2026, Medicare Advantage, Medicaid, CHIP, and Qualified Health Plan payers must respond to urgent prior authorization requests within 72 hours and standard requests within 7 calendar days. Many commercial payers still operate on longer timelines of 3–10 business days, depending on the service and clinical complexity.
Most major payers require prior authorization for advanced imaging (MRI, CT, PET, nuclear medicine), elective and complex surgeries, specialty and biologic medications, durable medical equipment (CPAP, power wheelchairs, infusion pumps), home health services, and certain specialist referrals. Requirements vary by payer, plan, and state — making payer-specific tracking essential.
A denied prior authorization can be appealed through a peer-to-peer review — a direct call between the treating physician and the payer's medical director. If denied again, a formal written appeal follows. Under CMS-0057-F, payers must now provide specific denial reasons, which RevalonMD uses to build targeted appeal documentation on the provider's behalf.
Retro authorization is payer approval requested after a service has already been delivered — typically in emergency or urgent situations where pre-service authorization was not possible. Retro auth requests carry a higher denial risk and often require stronger clinical documentation. RevalonMD manages retro authorization submissions to maximize approval probability and protect provider revenue.
A peer-to-peer review is a direct clinical conversation between the treating physician and the payer's medical director, requested after an initial prior authorization denial. It provides an opportunity to present additional clinical justification. RevalonMD coordinates peer-to-peer scheduling and prepares supporting documentation to strengthen the physician's case before the call.
Electronic prior authorization is the digital submission of PA requests through payer portals or EHR-integrated connections, replacing phone and fax workflows. Platforms like CoverMyMeds and Availity are widely used. CMS-0057-F mandates that covered payers support HL7 FHIR-based ePA APIs by January 1, 2027. RevalonMD submits electronically to reduce turnaround time.
Outsourcing prior authorization to RevalonMD eliminates the administrative burden of tracking payer-specific requirements. According to the 2025 AMA Prior Authorization Physician Survey, physicians spend an average of 13 hours per week on prior authorization. RevalonMD's AAPC- and AHIMA-certified team handles the full auth lifecycle — from benefit verification to approval tracking — across 50+ specialties in all 50 states.
Methodology: regulatory claims on this page cite the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F, January 17, 2024); burden statistics cite the 2025 AMA Prior Authorization Physician Survey and the AMA’s May 2026 reform-pledge survey. Performance figures (99% first-pass, 2.99% starting rate) are RevalonMD operating targets, reviewed every six months and signed off by the Founder before publication — not industry averages presented as guarantees. Medical-code references name their code year (CPT 2026; ICD-10-CM FY2026) and are verified by the Coding Director before publish.
Free authorization workflow assessment · written findings summary · recommended payer-specific workflow. Practice profile only — no PHI required to book.